HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Acute generalized exanthematous pustulosis associated with diltiazem].

Abstract
Acute generalized exanthematous pustulosis (AGEP) usually presents with the acute appearance of oedematous and erythematous lesions, on which multiple sterile pustules appear, associated with fever. Almost 90% of cases are associated with drugs, with antibiotics (penicillins and macrolides) being the most frequent causative agents. We describe a 36-year-old female patient, which started diltiazem 120mg/day for hypertension. After 6 days of therapy, multiple erythematous and oedematous lesions appeared, with associated multiple small non-follicular pustules. Oral corticosteroids were started, with progressive and complete improvement. Patch-tests were performed, which revealed positivity for diltiazem. Although a rare entity, AGEP must be considered in cases of acute eruptions with disseminated pustules and fever. The use of patch tests in this disease may be useful as positive reactions are frequent.
AuthorsVasco Serrão, Luísa Caldas Lopes, J M Campos Lopes, Lurdes Lobo, Ana Ferreira
JournalActa medica portuguesa (Acta Med Port) 2008 Jan-Feb Vol. 21 Issue 1 Pg. 99-102 ISSN: 1646-0758 [Electronic] Portugal
Vernacular TitlePustulose generalizada exantemática aguda associada ao diltiazem.
PMID18489841 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Diltiazem
Topics
  • Acute Disease
  • Adult
  • Antihypertensive Agents (adverse effects)
  • Diltiazem (adverse effects)
  • Drug Eruptions (etiology)
  • Exanthema (chemically induced)
  • Female
  • Humans
  • Skin Diseases, Vesiculobullous (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: